EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody

Pietro E Doneddu iD, Marta Ruiz, Elisa Bianchi, Giuseppe Liberatore iD, Fiore Manganelli iD, Dario Cocito, Giuseppe Cosentino, Luana Benedetti iD, Girola A Marfia, Massimiliano Filosto iD, Chiara Briani iD, Claudia Giannotta and 1 more

European Journal of Neurology · 2023-02 · 30 (2) · 501-510

DOI: 10.1111/ene.15296 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2022-03-06. Written by Pietro E Doneddu and 12 co-authors. Institution: Neuromuscular and Neuroimmunology Service, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Major MEDLINE topics: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Polyradiculoneuropathy. Cited 19 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and purpose A diagnostic score was developed to discriminate anti‐myelin‐associated‐glycoprotein (MAG) neuropathy from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and applied it to patients with atypical anti‐MAG neuropathy.

Methods

The clinical and electrophysiological features of patients with a diagnosis of typical anti‐MAG neuropathy were compared to those of patients with a diagnosis of CIDP. The association of each feature with the diagnosis was assessed in the two groups. Features showing a significant association with the diagnosis were included in a multivariable logistic regression model and adjusted odds ratios were estimated for each feature. A score ranging from 1 to 3 was applied to each feature based on the magnitude of the estimated odds ratios. The score was then applied to patients with a clinical diagnosis of CIDP who also had high anti‐MAG antibody titers (CIDP‐MAG).

Results

Thirty‐one anti‐MAG neuropathy patients, 45 typical CIDP patients and 16 CIDP‐MAG patients were included. Scores in anti‐MAG antibody patients ranged from 1 to 5 and in CIDP patients from −7 to −1. Using the score, 4/16 CIDP‐MAG patients were diagnosed to have anti‐MAG neuropathy and 12/16 patients to have CIDP. Response to intravenous immunoglobulin in the CIDP‐MAG patients classified as CIDP was similar to that of definite CIDP patients and higher than that of anti‐MAG neuropathy patients.

Conclusions

Our score allowed an accurate discrimination to be made, amongst patients with anti‐MAG antibodies, of those affected by CIDP and the patients with anti‐MAG neuropathy. This score may help proper treatment to be chosen for patients with anti‐MAG antibodies with a CIDP‐like presentation.

Subjects

MeSH terms (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingPolyradiculoneuropathyHumansImmunoglobulin MImmunoglobulins, IntravenousAutoantibodiesMyelin-Associated Glycoprotein

Author keywords

CIDPMAGantibodychronic inflammatory demyelinating polyradiculoneuropathydiagnostic criterianeuropathy

Substances

Immunoglobulin MImmunoglobulins, IntravenousAutoantibodiesMyelin-Associated Glycoprotein

Authors and institutions

  • Neuromuscular and Neuroimmunology Service, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Laboratorio di Malattie Neurologiche, IRCCS-Istituto Mario Negri, Milan, Italy.
  • Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
  • Presidio Sanitario Major, Istituti Clinici Scientifici Maugeri, Turin, Italy.
  • IRCCS Foundation C. Mondino National Neurological Institute, Pavia, Italy.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy.

ORCID profiles: Pietro E Doneddu, Giuseppe Liberatore, Fiore Manganelli, Luana Benedetti, Massimiliano Filosto, Chiara Briani, Eduardo Nobile-Orazio

Cite

APA

Doneddu, P. E., Ruiz, M., Bianchi, E., Liberatore, G., Manganelli, F., Cocito, D., Cosentino, G., Benedetti, L., Marfia, G. A., Filosto, M., Briani, C., Giannotta, C., & Nobile-Orazio, E. (2023). A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody. European Journal of Neurology, 30(2), 501-510. https://doi.org/10.1111/ene.15296

Vancouver

Doneddu PE, Ruiz M, Bianchi E, Liberatore G, Manganelli F, Cocito D, et al. A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody. European Journal of Neurology. 2023;30(2):501-510. doi:10.1111/ene.15296

BibTeX
@article{Doneddu2023,
  author = {Doneddu, Pietro E and Ruiz, Marta and Bianchi, Elisa and Liberatore, Giuseppe and Manganelli, Fiore and Cocito, Dario and Cosentino, Giuseppe and Benedetti, Luana and Marfia, Girola A and Filosto, Massimiliano and Briani, Chiara and Giannotta, Claudia and Nobile-Orazio, Eduardo},
  title = {A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {2},
  pages = {501--510},
  doi = {10.1111/ene.15296}
}
Start for free →